A Systematic Framework to Rapidly Obtain Data on Patients with Cancer and COVID-19: CCC19 Governance, Protocol, and Quality Assurance

The COVID-19 and Cancer Consortium

Résultat de rechercheexamen par les pairs

23 Citations (Scopus)

Résumé

When the COVID-19 pandemic began, formal frameworks to collect data about affected patients were lacking. The COVID-19 and Cancer Consortium (CCC19) was formed to collect granular data on patients with cancer and COVID-19 at scale and as rapidly as possible. CCC19 has grown from five initial institutions to 125 institutions with >400 collaborators. More than 5,000 cases with complete baseline data have been accrued. Future directions include increased electronic health record integration for direct data ingestion, expansion to additional domestic and international sites, more intentional patient involvement, and granular analyses of still-unanswered questions related to cancer subtypes and treatments.

Langue d'origineEnglish
Pages (de-à)761-766
Nombre de pages6
JournalCancer Cell
Volume38
Numéro de publication6
DOI
Statut de publicationPublished - déc. 14 2020

Financement

Bailleurs de fondsNuméro du bailleur de fonds
Hope Foundation for Cancer ResearchMRSG-16-152-01-CCE
NCATS/NIH
National Institutes of Health
American Cancer Society
National Cancer InstituteP30CA177558, P30 CA068485, P30 CA054174, U01 CA231840
National Center for Advancing Translational Sciences
Vanderbilt Institute for Clinical and Translational ResearchUL1 TR000445
Korean Foundation for Cancer Research

    ASJC Scopus Subject Areas

    • Oncology
    • Cancer Research

    Empreinte numérique

    Plonger dans les sujets de recherche 'A Systematic Framework to Rapidly Obtain Data on Patients with Cancer and COVID-19: CCC19 Governance, Protocol, and Quality Assurance'. Ensemble, ils forment une empreinte numérique unique.

    Citer